Literature DB >> 24817260

Alternative treatment modalities for the hypogonadal patient.

Landon W Trost1, Mohit Khera.   

Abstract

Testosterone (T) deficiency syndrome (TDS) is a prevalent condition, commonly managed with exogenous T. Despite an abundance of T formulations, alternative treatments are often sought for various reasons. To evaluate outcomes of alternative therapies, a PubMed search was performed of all publications that included men with TDS from 1990 through October 2013, with results summarized. Proposed mechanisms of action were also reviewed to provide a pathophysiologic basis for reported outcomes. Nonpharmacologic therapies that increase endogenous T are weight loss, exercise, and varicocelectomy, while medications used off-label include aromatase inhibitors, human chorionic gonadotropin, and selective estrogen receptor modulators. All reported therapies increase T, while changes in estradiol and adverse events vary by therapeutic class. Although limited data preclude direct comparisons between therapies, exercise and weight loss alone or in combination with medications may be considered first line. The role for surgical therapy in TDS remains undefined and requires further study.

Entities:  

Mesh:

Year:  2014        PMID: 24817260     DOI: 10.1007/s11934-014-0417-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  88 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

Authors:  A Vermeulen; J M Kaufman; V A Giagulli
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

3.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

4.  Outcomes of clomiphene citrate treatment in young hypogonadal men.

Authors:  Darren J Katz; Omar Nabulsi; Raanan Tal; John P Mulhall
Journal:  BJU Int       Date:  2011-11-01       Impact factor: 5.588

Review 5.  Testosterone and depression: systematic review and meta-analysis.

Authors:  Fahd Aziz Zarrouf; Steven Artz; James Griffith; Cristian Sirbu; Martin Kommor
Journal:  J Psychiatr Pract       Date:  2009-07       Impact factor: 1.325

6.  Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.

Authors:  Sherri-Ann M Burnett-Bowie; Kristen C Roupenian; Melissa E Dere; Hang Lee; Benjamin Z Leder
Journal:  Clin Endocrinol (Oxf)       Date:  2009-01       Impact factor: 3.478

7.  Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.

Authors:  Sherri-Ann M Burnett-Bowie; Elizabeth A McKay; Hang Lee; Benjamin Z Leder
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

8.  Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.

Authors:  E L Rhoden; A Morgentaler
Journal:  Int J Impot Res       Date:  2004-02       Impact factor: 2.896

9.  Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men.

Authors:  Vincenzo Rochira; Lucia Zirilli; Bruno Madeo; Laura Maffei; Cesare Carani
Journal:  J Steroid Biochem Mol Biol       Date:  2008-12-30       Impact factor: 4.292

10.  Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

Authors:  A T Guay; J Jacobson; J B Perez; M B Hodge; E Velasquez
Journal:  Int J Impot Res       Date:  2003-06       Impact factor: 2.896

View more
  2 in total

Review 1.  Review of health risks of low testosterone and testosterone administration.

Authors:  Huanguang Jia; Charles T Sullivan; Sean C McCoy; Joshua F Yarrow; Matthew Morrow; Stephen E Borst
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 2.  Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.

Authors:  Szidónia Farkas; Adrienn Szabó; Anita Emőke Hegyi; Bibiána Török; Csilla Lea Fazekas; Dávid Ernszt; Tamás Kovács; Dóra Zelena
Journal:  Biomedicines       Date:  2022-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.